Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Heloisa Zorzi Costa"'
Autor:
Iris Mattos Santos Pirath, Heloisa Zorzi Costa, Chandra Chiappin Cardoso, Andressa Oliveira Martin Wagner, Maria Claudia Santos da Silva
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp 7- (2023)
Paciente de 79 anos, sexo feminino, com histórico de câncer de mama em remissão (uso de hormonioterapia adjuvante com anastrozol), diabetes mellitus tipo 2 e hipotireoidismo.No momento da admissão no Hospital Universitário da Universidade Federa
Externí odkaz:
https://doaj.org/article/f8383d2a71af464183eb949669f888db
Autor:
Laura Otto Walter, Chandra Chiappin Cardoso, Íris Mattos Santos‐Pirath, Heloisa Zorzi Costa, Rafaela Gartner, Isabel Werle, Eduarda Talita Bramorski Mohr, Julia Salvan da Rosa, Tainá Larissa Lubschinski, Mariano Felisberto, Iara Fabricia Kretzer, Ivete Ioshiko Masukawa, Patrícia de Almeida Vanny, Magali Chaves Luiz, Ana Carolina Rabello de Moraes, Eduardo Monguilhott Dalmarco, Maria Cláudia Santos‐Silva
Publikováno v:
Immunology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48b60674ff837db72dd43231f43e25a9
https://doi.org/10.1111/imm.13635
https://doi.org/10.1111/imm.13635
Autor:
Laura Otto Walter, Chandra Chiappin Cardoso, Íris Mattos Santos‐Pirath, Heloisa Zorzi Costa, Rafaela Gartner, Isabel Werle, Eduarda Talita Bramorski Mohr, Julia Salvan Rosa, Mariano Felisberto, Iara Fabricia Kretzer, Ivete Ioshiko Masukawa, Patrícia de Almeida Vanny, Magali Chaves Luiz, Ana Carolina Rabello Moraes, Eduardo Monguilhott Dalmarco, Maria Cláudia Santos‐Silva
Publikováno v:
Immunology. 165:481-496
Coronavirus disease 2019 (COVID-19) is a respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and marked by an intense inflammatory response and immune dysregulation in the most severe cases. In order to better
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f6113248c281c1ec3035446ac5021dc
https://doi.org/10.1111/imm.13457
https://doi.org/10.1111/imm.13457
Autor:
Heloísa Zorzi Costa, Noemi Farah Pereira, Luciane kaminski, Ricardo Pasquini, Vaneuza Araujo Moreira Funke, Ana Lucia Vieira Mion
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 40, Iss 4, Pp 363-367 (2018)
Introduction: Mutations in the breakpoint cluster region-Abelson murine leukemia 1 gene are the leading cause of resistance to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients. Mutations have been detected throughout the
Externí odkaz:
https://doaj.org/article/d1b5b81f328847d18731c0313b1f7648